Interleukin-10: An anti-inflammatory cytokine with therapeutic potential

Clinical and Experimental Allergy

Volumn 29, Issue 9, 1999, Pages 1164-1171

  Pretolani, M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; CHEMOKINE; CYCLIC AMP; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; EOSINOPHILIA; HELPER CELL; HUMAN; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; TH1 CELLS; TH2 CELLS;

EID: 0032817355     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00456.x     Document Type: Review

References (76)

1. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148:3618-23.
2. Platzer C, Meisel Ch, Vogt K, Platzer M, Volk H-D. Upregulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int Immunol 1994; 7:517-23.
3. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol 1995; 155:4909-16.
4. Taniyama T, Takai S, Miyazaki E et al. The human interleukin-10 receptor gene maps to chromosome 11q23.3. Human Gen 1995; 95:99-101.
5. Liu Y, Wei SHY, Ho ASY, Malefyt RD, Moore KM. Expression, cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152:1821-9.
6. Tan JC, Braun S, Rong H et al. Characterization of recombinant extracellular domain of human interleukin-10 receptor. J Biol Chem 1995; 270:12906-11.
7. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cells. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 1989; 170:2081-95.
8. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-90.
9. Lalani I, Bhol K, Razzaque Ahmed A. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79:469-4.
10. Goldman M, Velu T, Pretolani M. Interleukin-10. Actions and therapeutical potentials. Biodrugs 1997; 7:6-14.
11. Durez P, Abramowiez D, Gérard C et al. In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med 1993; 177:551-5
12. Marchant A, Amraoui Z, Gueydan C et al. Methyl-prednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin Exp Immunol 1996; 106:91-6.
13. John M, Lim S, Scybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 alpha, granulocyte-macrophage colony-stimulating factor, and interferon gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
14. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994; 83:2678-83.
15. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994; 153:811-16.
16. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by trasforming growth factor-beta and interleukin-10. J Biol Chem 1992; 267:23301-8.
17. Brown CY, Lagnado CA, Vadas MA, Goodall GI. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem 1996; 271:20108-12.
18. Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O. Differential regulation of IL-5 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996; 156:2591-8.
19. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994; 179:1695-9.
20. Fleming SD, Campbell PA. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. J Immunol 1996; 156:1143-150.
21. Kasama T, Strieter RM, Lukaes NW, Burdick MD, Kunkel SL. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152:3559-69.
22. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
23. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
24. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146:374-7.
25. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
26. Sanderson CJ. Interleukin-5, eosinophils and diseases. Blood 1992; 79:3101-9.
27. Schandené L, Alonso-Vega C, Willems F et al. B7/CD28- dependent IL-5 production by human resting T-cells is inhibited by IL-10. J Immunol 1994; 152:4368-74.
28. Del Prete G, De Carli M, Almerigogna F, Giudizi G, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (TH1) and type 2 helper (TH2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
29. + T-lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol 1996; 157:377-84.
30. Pretolani M, Goldman M. IL-10: a potential therapy for allergic inflammation? Immunol Today 1997; 18:277-80.
31. Lopez AF, Elliott MJ, Woodcock J, Vadas MA. GM-CSF, IL-3 and IL-5: cross competition on human haemopoietic cells. Immunol Today 1992; 13:495-500.
32. Rollins BJ. Chemokines. Blood 1997; 90:909-28.
33. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:565-8.
34. Humbles AA, Conroy DM, Marleau S et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997; 186:601-12.
35. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997; 158:4398-404.
36. Berkman N, John M, Roesems G, Jose PJ, Barnes PJ, Chung KF. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol 1995; 155:4412-18.
37. Polentarutti N, Introna M, Sozzani S, Mancinelli R, Mantovani G, Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw 1997; 8:271-4.
38. John M, Hirst SJ, Jose PJ et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 1997; 158:1841-7.
39. Gonzalo JA, Lloyd CM, Kremer L et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996; 98:2332-45.
40. Hogaboam C, Kunkel SL, Strieter RM et al. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998; 160:6166-71.
41. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180:711-15.
42. Ohkawara Y, Lim KG, Glibetic M, Nakano K, Dolovich J, Croitorn K, Weller PF, Jordana M. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996; 97:1761-6.
43. Warner JA, Kroegel C. Pulmonary immune cells in health and disease: mast cells and basophils. Eur Respir J 1994; 7:1326-41.
44. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346:274-6.
45. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9:317-43.
46. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. IL-10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173:507-10.
47. Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 1996; 26:166-70.
48. Marshall JS, Leal-Berumen I, Nielsen L, Glibetic M, Jordana M. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal cells. J Clin Invest 1996; 97:1122-8.
49. Coyle AJ, Le Gros G, Bertrand C et al. Interleukin-4 is required for the induction of lung TH2 mucosal immunity. Am J Respir Cell Mol Biol 1995; 13:54-9.
50. Zuany-Amorim C, Ruffié C, Hailé S, Vargaftig BB, Pereira P, Pretolani M. Requirement for γδ T cells in allergic airway inflammation. Science 1998; 280:1265-7.
51. Zuany-Amorim C, Hailé S, Ledue D et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95:2644-51.
52. Rennick D, Davidson N, Berg D. Interleukin-10 gene knockout mice: a model of chronic inflammation. Clin Immunol Immunopathol 1995; 76:S174-8.
53. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997; 185:1089-99.
54. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182:99-108.
55. Bécherel P-A, Le Goff L, Ktorza S et al. Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol 1995; 25:2992-5.
56. Pretolani M, Goldman M. Cytokines involved in the downregulation of allergic airway inflammation. Res Immunol 1996; 68th Forum in Immunology, 33-8.
57. Bradley LM, Yoshimoto K, Swain SL. IFN-γ and IL-12 regulate the subsets of memory effector/helper T cells in vitro. J Immunol 1995; 155:1713-24.
58. + T cells. J Exp Med 1993; 177:573-6.
59. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993; 148:1102-4.
60. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995; 92:8960-4.
61. Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990; 145:2950-8.
62. Czech W, Krutmann J, Budnik A, Schopf E, Kapp A. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 1993; 100:417-23.
63. Busse WW. Viral infections in humans. Am J Respir Crit Care Med 1995; 151:1675-7.
64. Barnes PJ. Mechanisms of action of glucocorticosteroids. Am J Respir Crit Care Med 1996; 148:S21-7.
65. Corriga CJ, Hamid Q, North J et al. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a TH2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567-78.
66. Druilhe A, Cai Z, Hailé S, Chouaib S, Pretolani M. Fasmediated apoptosis in cultured human eosinophils. Blood 1996; 87:2822-30.
67. Meagher LC, Cousin JM, Seekl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422-8.
68. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:237-43.
69. Huhn RD, Radwanski E, O'Connell SM et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996; 87:699-705.
70. Wissing KM, Morelon E, Legendre C et al. A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation 1997; 64:999-1006.
71. Asadullah K, Sterry W, Stephanek K et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutical approach. J Clin Invest 1998; 101:783-94.
72. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97: 1288-96.
73. Martin RJ, Boguniewiez Henson JE, Celniker AC, Williams M, Giorno RC, Leung DY., The cffects effects of inhaled interferon gamma in normal human airways. Am Rev Respir Dis 1993; 148:1677-82.
74. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin 10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000.
75. Llorente L, Zou WP, Levy Y et al. Role of interleukin-10 in the B lymphocyte hyperreactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
76. Rousset F, Garcia E, Defrance T et al. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89:1890-3.